BackgroundThe Strengths and Difficulties Questionnaire (SDQ) is a tool to measure the risk for mental disorders in children. The aim of this study is to describe the diagnostic efficiency and internal structure of the SDQ in the sample of children studied in the Spanish National Health Survey 2006.MethodsA representative sample of 6,773 children aged 4 to 15 years was studied. The data were obtained using the Minors Questionnaire in the Spanish National Health Survey 2006. The ROC curve was constructed and calculations made of the area under the curve, sensitivity, specificity and the Youden J indices. The factorial structure was studied using models of exploratory factorial analysis (EFA) and confirmatory factorial analysis (CFA).ResultsThe prevalence of behavioural disorders varied between 0.47% and 1.18% according to the requisites of the diagnostic definition. The area under the ROC curve varied from 0.84 to 0.91 according to the diagnosis. Factor models were cross-validated by means of two different random subsamples for EFA and CFA. An EFA suggested a three correlated factor model. CFA confirmed this model. A five-factor model according to EFA and the theoretical five-factor model described in the bibliography were also confirmed. The reliabilities of the factors of the different models were acceptable (>0.70, except for one factor with reliability 0.62).ConclusionsThe diagnostic behaviour of the SDQ in the Spanish population is within the working limits described in other countries. According to the results obtained in this study, the diagnostic efficiency of the questionnaire is adequate to identify probable cases of psychiatric disorders in low prevalence populations. Regarding the factorial structure we found that both the five and the three factor models fit the data with acceptable goodness of fit indexes, the latter including an externalization and internalization dimension and perhaps a meaningful positive social dimension.Accordingly, we recommend studying whether these differences depend on sociocultural factors or are, in fact, due to methodological questions.
The use of biomass
for the production of energy and higher added
value products is a topic of increasing interest in line with growing
environmental concerns and circular economy. Mesoporous material Sn-In-MCM-41
was synthesized for the first time and used as a catalyst for the
transformation of sugars to methyl lactate (ML). This catalyst was
characterized in depth by various techniques and compared with Sn-MCM-41
and In-MCM-41 catalysts. In the new Sn-In-MCM-41 material, both metals,
homogeneously distributed throughout the mesoporous structure of MCM-41,
actuate in a cooperative way in the different steps of the reaction
mechanism. As a result, yields to ML of 69.4 and 73.9% in the transformation
of glucose and sucrose were respectively reached. In the case of glucose,
the
ML yield 1.5 and 2.6 times higher than those of Sn-MCM-41 and In-MCM-41
catalysts, respectively. The Sn-In-MCM-41 catalyst was reused in the
transformation of glucose up to four cycles without significant loss
of catalytic activity. Finally, life cycle assessment comparison between
chemical and biochemical routes to produce ML allowed us to conclude
that the use of Sn-In-MCM-41 reduces the environmental impacts compared
to Sn-MCM-41. Nevertheless, to make the chemical route comparable
to the biochemical one, improvements in the catalyst and ML synthesis
have to be achieved.
MHPs have a high prevalence and a significant repercussion on the patient's life. An inverse relationship was found between certain risk factors for MHPs and the use of services, which suggests inequality. Problems of accessibility are identified.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.